JOHN FARMER to Hypolipidemic Agents
This is a "connection" page, showing publications JOHN FARMER has written about Hypolipidemic Agents.
Connection Strength
1.670
-
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis (the SEAS trial). Curr Atheroscler Rep. 2009 Mar; 11(2):82-3.
Score: 0.271
-
Diabetic dyslipidemia and atherosclerosis: evidence from clinical trials. Curr Atheroscler Rep. 2007 Aug; 9(2):162-8.
Score: 0.243
-
Optimal low-density lipoprotein levels: evidence from epidemiology and clinical trials. Curr Atheroscler Rep. 2006 Mar; 8(2):157-62.
Score: 0.220
-
Rationale for aggressive lipid lowering: evidence from clinical trials. Expert Rev Cardiovasc Ther. 2004 May; 2(3):305-9.
Score: 0.194
-
Economic implications of lipid-lowering trials: current considerations in selecting a statin. Am J Cardiol. 1998 Sep 24; 82(6A):26M-31M.
Score: 0.131
-
Choosing the right lipid-regulating agent. A guide to selection. Drugs. 1996 Nov; 52(5):649-61.
Score: 0.115
-
Current and future therapeutic approaches to hyperlipidemia. Adv Pharmacol. 1996; 35:79-114.
Score: 0.109
-
Antihyperlipidaemic agents. Drug interactions of clinical significance. Drug Saf. 1994 Nov; 11(5):301-9.
Score: 0.100
-
Comparative effects of simvastatin and lovastatin in patients with hypercholesterolemia. The Simvastatin and Lovastatin Multicenter Study Participants. Clin Ther. 1992 Sep-Oct; 14(5):708-17.
Score: 0.086
-
Diabetic dyslipidemia and atherosclerosis: evidence from clinical trials. Curr Diab Rep. 2008 Feb; 8(1):71-7.
Score: 0.063
-
The Heart Protection Study: expanding the boundaries for high-risk coronary disease prevention. Am J Cardiol. 2003 Jul 03; 92(1A):3i-9i.
Score: 0.046
-
Aggressive lipid therapy in the statin era. Prog Cardiovasc Dis. 1998 Sep-Oct; 41(2):71-94.
Score: 0.033
-
Effects of lipid lowering therapy on progression of coronary and carotid artery disease. Curr Opin Lipidol. 1997 Dec; 8(6):354-61.
Score: 0.031
-
Effect of gemfibrozil on levels of lipoprotein[a] in type II hyperlipoproteinemic subjects. J Lipid Res. 1996 Jun; 37(6):1298-308.
Score: 0.028